IU, Cook Medical announce 5-year agreement to advance research and innovation
The IU Launch Accelerator for Biosciences, or IU LAB, based in Indianapolis, will serve as the coordinating organization for projects launched as part of the initiative.
The IU Launch Accelerator for Biosciences, or IU LAB, based in Indianapolis, will serve as the coordinating organization for projects launched as part of the initiative.
SIHO Insurance Services is tackling the gargantuan challenge of growth in the employer-based benefits market in Indianapolis and across the state.
The recently established Indy Health District is dedicated to reducing health inequity across Indianapolis. It stretches from St. Clair Street north to 38th Street, encompassing 1,500 acres.
Susan Monarez isn’t “aligned with” President Donald Trump’s agenda and refused to resign as head of the Centers for Disease Control and Prevention, so the White House terminated her, spokesman Kush Desai said Wednesday night.
Over the next two years, Purdue will launch 15 new academic offerings spread between undergraduate and graduate degrees and a few certificate programs.
Indiana Gov. Mike Braun said the agreement “enables Elanco and its partners, including Purdue University, to accelerate the creation of an innovation district in downtown Indianapolis.”
Many patients in their 50s simply want to end chronic joint pain from arthritis, injuries and years of wear and tear to get back to hiking or to take up pickleball.
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Trump sent letters to 17 of the world’s largest drugmakers earlier this month, including Lilly and Novo Nordisk A/S, insisting they lower what they charge Medicaid in the U.S. for existing drugs.
The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe Lilly medications including Zepbound and Mounjaro.
Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand for direct sales. Lilly is working with Truepill and Amazon.com Inc.’s pharmacy unit on its platform.
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
The grant will fund a new center at the medical school which will be one of only two in the U.S. dedicated to developing stem-cell-based models of the brain to better understand Alzheimer’s disease.
The University of Indianapolis is launching a program this month to prepare nurse practitioners, long a fixture in primary care exam rooms, to care for complex and critically ill patients in hospitals.
The new late-stage study will focus on people who are at risk of cognitive decline.
New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north-side warehouse transformed with $160 million into a clean-room manufacturing site for radiopharmaceutical cancer therapies.
Lilly previously secured approval for Kisunla in the U.S., Japan and the U.K.
The health care system is making big changes, down to the smallest details, for the 864 patient rooms in the academic hospital system’s massive new downtown hospital.
BiomEdit said the disease it’s targeting, avian necrotic enteritis, causes an estimated $6 billion in annual losses worldwide.
Mills joined Community in 1985 when it was a single hospital. Today, it operates five acute-care hospitals (with a sixth in the works), a cardiovascular hospital, a recovery center, three rehabilitation hospitals and a freestanding behavioral health hospital.